Connection
Rohit Katial to Anti-Allergic Agents
This is a "connection" page, showing publications Rohit Katial has written about Anti-Allergic Agents.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
1.025 |
|
|
|
-
Hoyte FC, Meltzer EO, Ostrom NK, Nelson HS, Bensch GW, Spangler DL, Storms WW, Weinstein SF, Katial RK. Recommendations for the pharmacologic management of allergic rhinitis. Allergy Asthma Proc. 2014 May-Jun; 35 Suppl 1:S20-7.
Score: 0.453
-
Katial RK, Oppenheimer JJ, Ostrom NK, Mosnaim GS, Yancey SW, Waitkus-Edwards KR, Prillaman BA, Ortega HG. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Jan-Feb; 31(1):68-75.
Score: 0.335
-
Weinstein SF, Katial R, Jayawardena S, Pirozzi G, Staudinger H, Eckert L, Joish VN, Amin N, Maroni J, Rowe P, Graham NMH, Teper A. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. J Allergy Clin Immunol. 2018 07; 142(1):171-177.e1.
Score: 0.147
-
Katial RK, Meltzer EO, Lieberman P, Ratner PH, Berger WE, Kaliner MA, Siegel CJ, Bukstein DA, Ciervo CA, Marple B. Suggested updated approaches to patient management. Ann Allergy Asthma Immunol. 2011 Feb; 106(2 Suppl):S17-9.
Score: 0.090
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|